OnKure Therapeutics, Inc. (OKUR) Form 10-K Annual Reports
OnKure Therapeutics, Inc. (OKUR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: OKUR
CIK: 1637715
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerMathieu Groh
Audit LocationDenver, Colorado, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-07 | — | SCHEDULE 13G Filing | 0001104659-26-114447 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 Filing | 0001609284-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-23 | 2026-09-21 | 4 Filing | 0001692747-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097335 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002177 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001493152-26-038382 | View SEC Doc Filr Page |
| 4/A | 2026-08-13 | 2026-08-07 | 4/A Filing | 0001622769-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-07 | 8-K | 0001193125-26-347315 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 | 0001193125-26-344874 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001547100-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001921956-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001622769-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001889716-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001240122-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001644467-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001609284-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001692747-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0002037442-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-08-11 | 2026-08-07 | 4 Filing | 0001748961-26-000002 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-10 | — | SCHEDULE 13G/A Filing | 0001617201-26-000003 | View SEC Doc Filr Page |
| 424B5 | 2026-08-04 | — | 424B5 | 0001193125-26-332839 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-332809 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-332773 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0001609284-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-06-22 | 4 Filing | 0001692747-26-000003 | View SEC Doc Filr Page |